(VIANEWS) - Zillow Group (Z), Molina Healthcare (MOH), Syneos Health (SYNH) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Zillow Group (Z)
158.4% sales growth and 3.05% return on equity
Zillow Group, Inc., a digital real estate company, operates real estate brands on mobile applications and websites in the United States.
Zillow Group's sales growth this year is anticipated to be 97.3% and 51.9% for next year.
Year-on-year quarterly revenue growth grew by 70.5%, now sitting on 3.97B for the twelve trailing months.
Volume
Today's last reported volume for Zillow Group is 7923570 which is 25.35% above its average volume of 6320710.
Zillow Group's sales growth for the next quarter is 158.4%. The company's growth estimates for the ongoing quarter and the next is a negative 56.8% and negative -70.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.05%.
Volatility
Zillow Group's last day, last week, and last month's current volatility was 2.45%, 10.46%, and 4.80%, respectively.
Zillow Group's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.22% (day), 9.49% (last week), and 5.36% (last month), respectively.
Zillow Group's Stock Yearly Top and Bottom Value
Zillow Group's stock is valued at $66.40 at 00:22 EST, way under its 52-week high of $208.11 and higher than its 52-week low of $63.13.
Zillow Group's Moving Average
Zillow Group's worth is way below its 50-day moving average of $89.13 and way below its 200-day moving average of $104.04.Previous days news about Zillow Group(Z)
- According to The Wall Street Journal on Tuesday, 9 November, "Investors are stepping up their scrutiny of Opendoor Technologies Inc. and Offerpad Solutions Inc., the two biggest players left in the iBuying industry after Zillow Group Inc. pulled the plug on this business."
- According to Bloomberg Quint on Friday, 5 November, "Cathie Wood's exchange-traded funds sold 1.8 million shares in Zillow Group Inc. on Thursday, after dumping 3.9 million shares a day earlier."
2. Molina Healthcare (MOH)
25.7% sales growth and 28.95% return on equity
Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.
Molina Healthcare's sales growth this year is expected to be 35.6% and 7.1% for next year.
Year-on-year quarterly revenue growth grew by 50.7%, now sitting on 22.6B for the twelve trailing months.
Volume
Today's last reported volume for Molina Healthcare is 134003 which is 47.05% below its average volume of 253118.
Molina Healthcare's sales growth is a negative 0% for the current quarter and 25.7% for the next. The company's growth estimates for the current quarter and the next is a negative 14.3% and 629.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.95%.
Volatility
Molina Healthcare's last day, last week, and last month's current volatility was 0.28%, 1.08%, and 1.08%, respectively.
Molina Healthcare's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.63% (day), 3.05% (last week), and 2.56% (last month), respectively.
Molina Healthcare's Stock Yearly Top and Bottom Value
Molina Healthcare's stock is valued at $305.38 at 00:22 EST, under its 52-week high of $312.52 and way higher than its 52-week low of $196.08.
Molina Healthcare's Moving Average
Molina Healthcare's value is higher than its 50-day moving average of $285.70 and way above its 200-day moving average of $265.12.3. Syneos Health (SYNH)
23.5% sales growth and 6.37% return on equity
Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America.
Syneos Health's sales growth this year is anticipated to be 18.8% and 8.5% for next year.
Year-on-year quarterly revenue growth grew by 3.9%, now sitting on 4.46B for the twelve trailing months.
Volume
Today's last reported volume for Syneos Health is 249370 which is 53.41% below its average volume of 535271.
Syneos Health's sales growth for the next quarter is 23.5%. The company's growth estimates for the ongoing quarter and the next is 13.5% and 27.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.37%.
Volatility
Syneos Health's last day, last week, and last month's current volatility was 3.00%, 2.76%, and 1.68%, respectively.
Syneos Health's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.65% (day), 3.98% (last week), and 2.67% (last month), respectively.
Syneos Health's Stock Yearly Top and Bottom Value
Syneos Health's stock is valued at $101.39 at 00:22 EST, below its 52-week high of $103.25 and way higher than its 52-week low of $59.39.
Syneos Health's Moving Average
Syneos Health's value is way higher than its 50-day moving average of $90.75 and way above its 200-day moving average of $88.65.4. Genesco (GCO)
12.5% sales growth and 16.59% return on equity
Genesco Inc. operates as a retailer and wholesaler of footwear, apparel, and accessories.
Genesco's sales growth this year is anticipated to be 33.6% and 2.2% for next year.
Year-on-year quarterly revenue growth grew by 92.9%, now sitting on 2.05B for the twelve trailing months.
Volume
Today's last reported volume for Genesco is 82409 which is 37.76% below its average volume of 132407.
Genesco's sales growth is a negative 0% for the ongoing quarter and 12.5% for the next. The company's growth estimates for the current quarter and the next is 56.5% and negative -2.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.59%.
Volatility
Genesco's last day, last week, and last month's current volatility was 0.23%, 2.31%, and 2.27%, respectively.
Genesco's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.48% (day), 3.26% (last week), and 3.47% (last month), respectively.
Genesco's Stock Yearly Top and Bottom Value
Genesco's stock is valued at $70.30 at 00:22 EST, below its 52-week high of $71.19 and way higher than its 52-week low of $21.88.